BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 14, 2025
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
July 23, 2015
View Archived Issues
St. Jude, Thoratec show a lot of Heart in transaction: St. Jude shows it has 'heart' with proposed $3.4B Thoratec acquisition
St. Jude Medical (NYSE:STJ) (St. Paul, Minn.) said that it has agreed to acquire Thoratec (NASDAQ:THOR) (Pleasanton, Calif.) for $63.50 per share in a cash transaction valued at about $3.4 billion.
Read More
Inside the Beltway: Harmonization of GCPs seen as sticking point for OUS trials draft
Read More
Government programs still solvent: Balancing act: Trustees say Part A trust fund solvent through 2030
Read More
India's first materiovigilance program: India launches first program to track adverse effects of devices
Read More
BSX Initiates Fast Study: New generation bioabsorbable scaffolds may challenge DES
Read More
Financings: MedGenome receives $20M investment in Series B round
Read More
Agreements/contracts: Syngnis pulls a Double Switch with Thermo Fisher Scientific
Read More
People in places
Read More
Product briefs
Read More
Briefly Noted
Read More
MDD's Orthopedics Extra
Read More
